| Previous Section | Index | Home Page |
Pharmaceutical Services Negotiating Committee
3. Mr. Turner: To ask the Secretary of State for Health when he last met the Pharmaceutical Services negotiating committee; and what was discussed. [2174]
The Minister for Health (Mr. Gerald Malone): Officials regularly meet the Pharmaceutical Services negotiating committee to discuss issues that affect community pharmacy contractors. Ministers meet the committee whenever it is appropriate.
Mr. Turner: I am sure that the Minister will have heard about the committee's anxieties and the cash flow problems that pharmacists are facing because his Department is an extremely bad payer. As he must be aware, small pharmacists in particular are concerned that they are not receiving within a proper time scale payment for prescriptions that they have already dispensed. That is making it impossible for them to solve their cash problems and they are creating redundancies. Should the attitude of the Minister's Department and the Government be causing redundancies at a time of massive unemployment? The Minister should stop his Department being such a bad payer and get on and pay the people the money that the Department owes them.
Mr. Malone: I read the briefing note that the hon. Gentleman is clearly using. It misses out a fact that perhaps the pharmacists did not discuss with him--if he had discussions with them and did not just read the note. A voluntary agreement that was negotiated with the pharmacists has been in place for some time. It sets out how the payments are structured so that they can be made as quickly as possible after the Prescription Pricing Authority has processed them. That agreement was highly welcomed when it was put in place and I am delighted to tell the hon. Gentleman that it is being honoured to the letter and payments are being made in the context of the agreement. Of course I recognise that pharmacists are business men and have to run their businesses in a proper way. They make a valuable contribution to the community and if there are any ways of taking that forward that we can discuss with them, I am always happy to do so.
Mr. Budgen: Does my hon. Friend agree that, like all other interest groups, pharmacists have a legitimate case? If the Opposition take up the arguments of every interest group in the community and ask the Government to pay 100 per cent. of their claims, public expenditure is bound to get out of control. Although it is certain that the Opposition will temporarily become popular with farmers, lawyers, civil servants and every other interest group that wants to get its snout into the public trough, that is a clear indication that public expenditure under Labour will get grossly out of control.
Mr. Malone: My hon. Friend is absolutely right. Every time that there is a request for additional funding, the Labour party accedes to it in the same breath as it suggests that taxation can be brought down, but those attitudes are incompatible. Unlike Labour, the pharmacists are always responsible when entering discussions. Last year the global sum from which they were paid was increased by some 2.5 per cent. The pharmacists also agreed to a change in the structure of the payments made to them, so that we can ensure that more payments go to pharmacists who provide more professional services. That was a welcome way to approach added public expenditure for added value. Labour says that payments should go up for no reason.
Mr. Ashton: Is the Minister aware that many people on regular prescriptions complain that chemists are giving short weight--that the doctor writes a prescription for 30 tablets but that the chemist dispenses only 24 or 26 tablets? People on regular monthly prescriptions are having to pay as much as one month extra per year because of that short measure. The pharmacists blame the packaging. Nevertheless, many members of the public feel cheated when they have paid more than £5 for a prescription but receive too few tablets. Will the Minister get together with the pharmaceutical and packaging industries to ensure that the customer gets what he pays for?
Mr. Malone: Rather curiously, the hon. Gentleman asked a question that might have more point in six months' time, as we introduce patient pack prescribing-- which is in its early days and has not yet been generally introduced. Pharmacists must dispense the appropriate medicine according to the doctor's prescription. That will be the case when patient pack prescribing is introduced. It will ensure that the patient is given the appropriate amount of medicine to treat the symptom for which he sought a prescription from the doctor.
Mr. Deva: Will my hon. Friend join me in paying tribute to the important role played by pharmacists in helping people with self-medication, which contrasts sharply with Labour's health policies--which are all diagnosis and no prescription?
Mr. Malone: My hon. Friend is absolutely right. Community pharmacists play an important role in providing medical care, and it is one that we are extremely keen to encourage through the payment of the professional allowance for displaying pharmacy practice leaflets and health promotion literature. Pharmacists, as health care professionals, are keen to develop that important role.
Breast Cancer
5. Mr. Gunnell: To ask the Secretary of State for Health if he will make a statement on his Department's progress towards the use of specialist breast units for the treatment of breast cancer. [2176]
The Parliamentary Under-Secretary of State for Health (Mr. John Bowis): The Calman report forms the basis of our strategy for the development of cancer services. We have charged regional directors with the task of taking that forward and, where necessary, reconfiguring services to treat common cancers, including breast cancer, in specialised units.
Mr. Gunnell: Given that the Calman report regarded as urgent the move to specialist breast cancer care units, which was endorsed by the Health Select Committee report, is sufficient urgency being shown by the Department? I think not. Is not it important that the Government move rapidly to establish a network of such units, so that the fears that haunt many women in this country can be allayed by the provision of prompt, effective and thorough treatment in every area? Is not that absolutely necessary? Why are the Government so dilatory in moving to that position?
Mr. Bowis: The hon. Gentleman is uncharacteristically ungenerous in not acknowledging the work being done by the NHS. Calman reported only in April, since when regional offices have been working on the
recommendations. Calman set out a structure of primary care refering to cancer units for diagnosis and treatment and cancer centres at which rarer types of cancer--and particular specialist services, such as radiotherapy-- would be available. The hon. Gentleman needs only to look in his own back yard. The United Leeds teaching hospitals have developed fine services that include a specialist unit. That is the way forward for Leeds, and the hon. Gentleman might have paid tribute to that development. We are looking to see how to develop services throughout the country for the benefit of patients.
Lady Olga Maitland: Will my hon. Friend join me in paying tribute to the Royal Marsden hospital in Sutton, in my constituency, which offers an excellent breast cancer service with particular expertise in early detection and palliative care? Does my hon. Friend agree that some of the extra budget allocated by the Chancellor should go to that superb service?
Mr. Bowis: I am happy to pay tribute to the Royal Marsden, and I was able to do so yesterday because I was at the Queen Elizabeth II centre when it received a charter mark award. I congratulate the hospital publicly again today. My hon. Friend is right to draw attention to the resources that my right hon. Friend the Secretary of State for Health has negotiated with my right hon. and learned Friend the Chancellor of the Exchequer--£1.3 billion more for the coming year; a 1.6 per cent. increase in real terms. I have no doubt that some of those resources will lead to further improvements in our cancer services.
Mr. McLeish: In view of the concern about high mortality rates for breast cancer, will the Minister reaffirm the Government's commitment to ensuring that a reduction in the mortality rate for breast cancer is a key part of the "Health of the Nation" strategy? Will he also confirm that he is satisfied with the progress that is being made to achieve the target of a 25 per cent. reduction by 2000? Will the Minister outline what steps he has taken to monitor progress at the district health authority level; and does he agree that the development and publication of local targets at DHA level is vital if the "Health of the Nation" strategy is to mean anything?
Mr. Bowis: There were about five questions there. I have already announced that our regional offices will examine the configuration of services, and will build on that. Of course we stand by our "Health of the Nation" targets. Progress has been made, and we want to see more. That is why we are developing services; why we are investing in services; and why much research is being done. I pay tribute to the range of research conducted by Government and by the voluntary sector and pharmaceutical companies.
| Next Section
| Index | Home Page |